Deranged liver function tests are frequently seen in patients receiving home parenteral nutrition (HPN) and HPN patients are at risk of a range of hepatic complications that may progress to significant and life-threatening liver damage. Chronic cholestasis, defined as 1.5 · upper limit of normal (ULN) of ‡ 2 of gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP) or bilirubin for > 6 months, has been shown to be associated with a 5-fold increase in the incidence of histologically advanced liver disease in HPN patients. The aim of the present study was to investigate prevalence of chronic cholestasis in a large cohort of HPN patients treated at a single Centre and to examine factors influencing its occurrence.
